Hypertensive Disorders of Pregnancy Linked to Declines in Cognition
MONDAY, March 6, 2023 (HealthDay News) -- Women with hypertensive disorders of pregnancy (HDP), specifically preeclampsia/eclampsia (PE/E), have greater declines in global cognition later in life, according to a study published online March 1 in Neurology.
Michelle M. Mielke, Ph.D., from the Wake Forest University School of Medicine in Winston-Salem, North Carolina, and colleagues examined the effects of any HDP, gestational or chronic hypertension (GH/CH), PE/E, and nulliparity on cognition in later life in a study involving 2,239 women enrolled in the Mayo Clinic Study of Aging with abstracted pregnancy information. Every 15 months, a cognitive battery of nine tests was conducted.
Of the participants, 1,854 (82.8 percent) had at least one pregnancy (1,607 all normotensive, 100 GH/CH, 147 PE/E) and 385 were nulliparous (17.2 percent). The researchers observed no cross-sectional difference in cognitive performance for women with a history of any HDP, GH/CH, or PE/E versus normotensive women; lower global and domain-specific cognition were seen for nulliparous women in age- and education-adjusted models, with an interaction seen for nulliparity and education. Compared with women with all normotensive pregnancies, longitudinally, women with any HDP had greater declines in global cognition and attention/executive z-scores. When stratified by HDP type, greater declines in global cognition, language, and attention z-scores were seen for women with PE/E only.
"While high blood pressure during pregnancy, including preeclampsia, is recognized as a risk factor for heart disease and stroke, our study suggests that it may also be a risk factor for cognitive decline in later life," Mielke said in a statement.
One author disclosed financial ties to the biopharmaceutical industry.
Abstract/Full Text (subscription or payment may be required)
Editorial (subscription or payment may be required)
Related Posts
Wife of California Congressman Died After Using Herbal Remedy
THURSDAY, Aug. 25, 2022 (HealthDay News) -- Lori McClintock, the wife of...
Los tratamientos con anticuerpos monoclonales contra la COVID-19: un experto los explica
MARTES, 31 de agosto de 2021 (HealthDay News) -- Las infusiones de anticuerpos...
Sacral Neuromodulation Safe for Lower Urinary Tract Dysfunction
FRIDAY, Oct. 7, 2022 (HealthDay News) -- Sacral neuromodulation (SNM) is safe...
Mind-Controlled Wheelchair Brings New Freedom to People With Paralysis
FRIDAY, Nov. 18, 2022 (HealthDay News) -- A severely paralyzed person no longer...